Last reviewed · How we verify
NCT02343237: FIBROPATHIC
Osteopathic Medicine in Fibromyalgia Syndrome
NA trial testing Osteopathic treatment in Fibromyalgia Syndrome in 101 participants. Completed in 27 July 2018.
20 July 2017
Quick facts
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 101 |
| Start date | 2 December 2015 |
| Primary completion | 20 July 2017 |
| Estimated completion | 27 July 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- Osteopathic treatment
- Factitious osteopathic treatment
Conditions studied
- Fibromyalgia Syndrome — all drugs for Fibromyalgia Syndrome →
Sponsor
Assistance Publique - Hôpitaux de Paris — full company profile →
Who can join
18 and older, any sex, with Fibromyalgia Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the analgesic effects of a 6 weeks osteopathic treatment on patients with fibromyalgia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Osteopathic medicine for fibromyalgia: a sham-controlled randomized clinical trial.
Coste J, Medkour T, Maigne JY, Pérez M, et al · · 2021 · cited 14× · PMID 33948127 · DOI 10.1177/1759720x211009017
Verify or expand the search:
- PubMed search for NCT02343237
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Osteopathic treatment
Trials testing the same drug.
- NCT06822348 — Short-term Effects of Osteopathic Manipulations on Heart Rate Variability in Lung Cancer Patients - A Randomized Pilot S · NA · not yet recruiting
- NCT07260422 — EVALUATION OF THE EFFECT OF OSTEOPATHIC TREATMENT ON CHRONIC NONSPECIFIC NECK PAIN · NA · completed
- NCT05726929 — Algology in Oncology Osteopathic Support (ALGOS) · NA · completed
- NCT04666415 — Impact of the Addition of a Specific and Personalized Body Approach by Osteopathic Treatment in the Care of Adolescents · NA · unknown
- NCT04125498 — The S-CARE Trial: Manual Treatment for C-sections Scars, a Pilot Study. · NA · suspended
Other recruiting trials for Fibromyalgia Syndrome
Currently open trials in the same condition.
- NCT07327775 — Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder · recruiting
- NCT06929598 — Shiatsu for Chronic Non-Inflammatory Pain in Children and Adolescents · NA · recruiting
- NCT06957873 — Craniovertebral Angle and Fibromyalgia Severity · recruiting
- NCT06539793 — Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome · NA · recruiting
- NCT05900466 — Metformin for Fibromyalgia Symptoms (INFORM Trial) · Phase 2 · recruiting
Other Assistance Publique - Hôpitaux de Paris trials
Trials by the same sponsor.
- NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
- NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
- NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
- NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
- NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02343237 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
- Last refreshed: 5 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02343237.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing